Showing results (1631-1640 of 1,800) with videos related to

Sort By:
Pageof 180
Hepatology Communications|July 29, 2022
Association of changes in histologic severity of nonalcoholic steatohepatitis and changes in patient-reported quality of lifeLaura Heath, Paul Aveyard, Jeremy W Tomlinson, et al.
Hepatology Communications|July 21, 2022
Speech patterns and enunciation for encephalopathy determination-A prospective study of hepatic encephalopathyAndrew M Moon, Hannah P Kim, Sarah Cook, et al.
Hepatology Communications|April 16, 2022
Distinct responsiveness to rifaximin in patients with hepatic encephalopathy depends on functional gut microbial speciesYoshimi Yukawa-Muto, Tomonori Kamiya, Hideki Fujii, et al.
Hepatology Communications|October 22, 2021
Frailty and the Risk of Acute Kidney Injury Among Patients With CirrhosisGiuseppe Cullaro, Elizabeth C Verna, Andres Duarte-Rojo, et al.
Hepatology Communications|October 22, 2021
Traf2 and NCK Interacting Kinase Is a Critical Regulator of Procollagen I Trafficking and Hepatic Fibrogenesis in MiceSamuel C Buchl, Zachary Hanquier, Andrew J Haak, et al.
Hepatology Communications|October 22, 2021
Low Lipoprotein(a) Levels Predict Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseMarica Meroni, Miriam Longo, Rosa Lombardi, et al.
Hepatology Communications|January 25, 2022
Nonalcoholic Fatty Liver Disease and Associated Risk Factors in a Community-Based Sample of Mexican-Origin AdultsDavid O Garcia, Kristin E Morrill, Melissa Lopez-Pentecost, et al.
Hepatology Communications|October 6, 2018
Placebo-Controlled Randomized Trial of an Intestinal Bile Salt Transport Inhibitor for Pruritus in Alagille SyndromeBenjamin L Shneider, Cathie Spino, Binita M Kamath, et al.
Hepatology Communications|October 6, 2018
Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular MortalityOmer Shahab, Rakesh Biswas, James Paik, et al.
Hepatology Communications|May 16, 2018
NI-0801, an anti-chemokine (C-X-C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acidKathy L de Graaf, Geneviève Lapeyre, Florence Guilhot, et al.
Pageof 180